SEM - Select Medical Holdings Corp Stock Price, Fair Value and News

27.72USD-0.45 (-1.60%)Market Closed

Market Summary

USD27.72-0.45

Market Closed

-1.60%

SEM Alerts

1 major insider sales recently.

SEM Stock Price

View Fullscreen

SEM RSI Chart

SEM Valuation

Market Cap

3.6B

Price/Earnings (Trailing)

14.61

Price/Sales (Trailing)

0.53

EV/EBITDA

8.94

Price/Free Cashflow

6.11

SEM Price/Sales (Trailing)

SEM Profitability

EBT Margin

5.74%

Return on Equity

18.9%

Return on Assets

3.17%

Free Cashflow Yield

16.36%

SEM Fundamentals

SEM Revenue

Revenue (TTM)

6.7B

Rev. Growth (Yr)

4.89%

Rev. Growth (Qtr)

-0.41%

SEM Earnings

Earnings (TTM)

243.5M

Earnings Growth (Yr)

68.23%

Earnings Growth (Qtr)

-3.97%

Breaking Down SEM Revenue

Last 7 days

3.3%

Last 30 days

-2.0%

Last 90 days

8.8%

Trailing 12 Months

-4.5%

How does SEM drawdown profile look like?

SEM Financial Health

Current Ratio

1.01

Debt/Equity

2.78

Debt/Cashflow

0.16

SEM Investor Care

Dividend Yield

1.8%

Dividend/Share (TTM)

0.5

Shares Dilution (1Y)

0.93%

Diluted EPS (TTM)

1.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	6.4B	6.5B	6.6B	6.7B
2022	6.3B	6.3B	6.3B	6.3B
2021	5.7B	6.0B	6.1B	6.2B
2020	5.5B	5.4B	5.4B	5.5B
2019	5.2B	5.2B	5.3B	5.5B
2018	4.5B	4.7B	4.9B	5.1B
2017	4.3B	4.3B	4.3B	0
2016	3.8B	4.1B	4.3B	0
2015	3.1B	3.2B	3.5B	0
2014	3.0B	3.0B	3.0B	0
2013	3.0B	3.0B	3.0B	3.0B
2012	2.9B	2.9B	2.9B	2.9B
2011	2.5B	2.6B	2.7B	2.8B
2010	0	2.3B	2.3B	2.4B
2009	0	0	0	2.2B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Select Medical Holdings Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 08, 2024	ortenzio robert a	sold	-1,495,000	29.9	-50,000	executive chairman
Mar 08, 2024	ortenzio robert a	sold	-1,415,000	28.3	-50,000	executive chairman
Feb 12, 2024	frist william h.	acquired	17,996	26.86	670	-
Feb 12, 2024	khanuja parvinderjit s.	acquired	17,996	26.86	670	-
Feb 08, 2024	ortenzio robert a	sold	-1,300,000	26.00	-50,000	executive chairman
Jan 08, 2024	ortenzio robert a	sold	-2,663,000	26.63	-100,000	executive chairman
Dec 14, 2023	ortenzio robert a	sold	-2,500,000	25.00	-100,000	executive chairman
Nov 01, 2023	malatesta michael f	acquired	564,000	22.56	25,000	chief financial officer
Nov 01, 2023	weigl christopher	acquired	282,000	22.56	12,500	chief accounting officer
Nov 01, 2023	khanuja parvinderjit s.	acquired	18,002	22.56	798	-

Which funds bought or sold SEM recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Gradient Investments LLC	unchanged	-	5.00	19.00	-%
Apr 23, 2024	WEDGE CAPITAL MANAGEMENT L L P/NC	added	65.81	1,199,920	2,264,360	0.04%
Apr 23, 2024	LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA	unchanged	-	131,804	2,688,210	0.03%
Apr 23, 2024	Global Retirement Partners, LLC	added	0.22	1,766	13,893	-%
Apr 23, 2024	FIFTH THIRD BANCORP	added	24.4	4,075	10,914	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-25.68	-49,000	1,000,000	0.01%
Apr 23, 2024	Louisiana State Employees Retirement System	reduced	-0.95	334,715	1,570,820	0.03%
Apr 23, 2024	WESBANCO BANK INC	new	-	1,137,650	1,137,650	0.04%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-97,254	1,291,230	0.01%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	added	19.27	2,863,410	8,263,460	0.01%

Are Funds Buying or Selling SEM?

Are funds buying SEM calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SEM

No. of Funds

SEM Alerts

1 major insider sales recently.

Unveiling Select Medical Holdings Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	vanguard group inc	10.13%	12,997,891	SC 13G/A
Feb 16, 2024	t. rowe price investment management, inc.	4.7%	5,964,606	SC 13G/A
Feb 14, 2024	t. rowe price investment management, inc.	4.7%	5,964,606	SC 13G
Feb 14, 2024	price t rowe associates inc /md/	13.3%	17,111,615	SC 13G/A
Feb 13, 2024	vanguard group inc	9.63%	12,347,798	SC 13G/A
Feb 02, 2024	ortenzio rocco a	6.07%	7,790,355	SC 13G/A
Feb 02, 2024	ortenzio robert a	6.98%	8,959,913	SC 13G/A
Jan 23, 2024	blackrock inc.	13.1%	16,843,479	SC 13G/A
Feb 14, 2023	t. rowe price investment management, inc.	5.2%	6,609,861	SC 13G
Feb 14, 2023	price t rowe associates inc /md/	16.2%	20,617,462	SC 13G/A

Recent SEC filings of Select Medical Holdings Corp

View All Filings

Date Filed	Form Type	Document
Apr 10, 2024	4	Insider Trading
Apr 10, 2024	SC 13G/A	Major Ownership Report
Apr 08, 2024	144	Notice of Insider Sale Intent
Mar 21, 2024	DEFR14A	DEFR14A
Mar 15, 2024	DEF 14A	DEF 14A
Mar 15, 2024	DEFA14A	DEFA14A
Mar 11, 2024	4	Insider Trading
Mar 08, 2024	144	Notice of Insider Sale Intent
Mar 04, 2024	ARS	ARS
Feb 26, 2024	PRE 14A	PRE 14A

Peers (Alternatives to Select Medical Holdings Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-12.72%	-6.73%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-3.19%	11.59%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-0.12%	51.97%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.62%	17.22%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.2	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.76	0.42	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	19.0M	21.3M	13.26%	5.28%	35.63	0.89	8.00%	-62.25%

Select Medical Holdings Corp News

Latest updates

Select Medical Holdings Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-0.4%	1,659	1,666	1,675	1,665	1,581	1,568	1,585	1,600	1,560	1,534	1,564	1,546	1,460	1,424	1,233	1,415	1,375	1,393	1,361	1,325	1,265
Costs and Expenses	0.6%	1,545	1,536	1,516	1,514	1,500	1,485	1,479	1,496	1,492	1,386	1,378	1,378	1,333	1,267	1,168	1,286	1,262	1,270	1,236	1,213	1,176
S&GA Expenses	6.7%	44.00	41.00	43.00	42.00	39.00	39.00	37.00	38.00	38.00	38.00	36.00	35.00	35.00	36.00	33.00	34.00	34.00	34.00	31.00	29.00	30.00
EBITDA Margin	3.1%	0.12*	0.11*	0.11*	0.11*	0.10*	0.10*	0.11*	0.14*	0.16*	0.17*	0.18*	0.16*	-	-	-	-	-	-	-	-	-
Interest Expenses	1.1%	51.00	50.00	49.00	49.00	47.00	45.00	41.00	36.00	34.00	34.00	34.00	34.00	36.00	34.00	37.00	46.00	44.00	54.00	51.00	51.00	51.00
Income Taxes	-24.7%	12.00	16.00	29.00	26.00	9.00	16.00	20.00	18.00	-8.64	28.00	66.00	45.00	35.00	32.00	23.00	22.00	12.00	13.00	21.00	18.00	11.00
Earnings Before Taxes	-3.8%	74.00	77.00	121	111	46.00	54.00	86.00	74.00	58.00	128	262	182	137	136	91.00	92.00	55.00	57.00	81.00	72.00	41.00
EBT Margin	6.5%	0.06*	0.05*	0.05*	0.05*	0.04*	0.04*	0.06*	0.08*	0.10*	0.12*	0.12*	0.10*	-	-	-	-	-	-	-	-	-
Net Income	-4.0%	46.00	48.00	78.00	71.00	28.00	27.00	55.00	49.00	50.00	77.00	165	111	77.00	77.00	52.00	53.00	32.00	31.00	45.00	41.00	25.00
Net Income Margin	7.1%	0.04*	0.03*	0.03*	0.03*	0.03*	0.03*	0.04*	0.05*	0.06*	0.07*	0.07*	0.06*	-	-	-	-	-	-	-	-	-
Free Cashflow	54.2%	179	116	235	51.00	13.00	94.00	172	6.00	-60.75	99.00	123	240	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	0.1%	7,690	7,684	7,702	7,700	7,665	7,555	7,552	7,536	7,360	7,899	7,956	7,921	7,655	7,660	7,468	7,116	7,340	7,155	7,107	7,021	5,964
Current Assets	-1.4%	1,258	1,276	1,304	1,314	1,271	1,217	1,221	1,251	1,139	1,779	1,868	1,835	1,594	1,624	1,363	998	1,213	1,050	1,028	1,053	993
Cash Equivalents	8.5%	84.00	77.00	101	84.00	98.00	108	95.00	131	74.00	748	803	750	577	640	510	73.00	336	136	124	148	175
Net PPE	1.7%	1,024	1,007	1,004	987	1,001	957	956	953	961	937	928	931	943	928	959	979	998	997	1,009	973	980
Goodwill	0.2%	3,513	3,505	3,486	3,485	3,484	3,479	3,476	3,465	3,449	3,400	3,391	3,390	3,379	3,369	3,391	3,391	3,392	3,383	3,385	3,324	3,321
Liabilities	-0.3%	6,116	6,134	6,166	6,247	6,275	6,187	6,206	6,127	5,995	5,909	5,985	6,124	6,004	5,899	5,800	5,520	5,437	5,295	5,267	5,264	4,268
Current Liabilities	7.1%	1,248	1,166	1,188	1,186	1,155	1,197	1,242	1,189	1,273	1,326	1,409	1,540	1,438	1,345	1,256	844	914	870	853	885	705
Long Term Debt	-2.9%	3,588	3,695	3,695	3,767	3,835	3,750	3,724	3,738	3,556	3,384	3,386	3,387	3,389	-	-	-	3,420	3,337	3,350	3,299	3,250
Shareholder's Equity	1.6%	1,288	1,268	1,502	1,418	1,122	1,335	1,304	1,367	1,326	1,364	1,450	1,351	1,253	1,219	1,172	975	929	906	996	925	916
Retained Earnings	4.0%	752	723	697	635	581	570	566	596	593	639	713	625	553	537	496	317	280	269	353	314	320
Additional Paid-In Capital	2.3%	493	482	474	462	452	445	442	490	504	502	516	514	509	501	497	492	491	485	493	488	483
Shares Outstanding	0.1%	128	128	127	127	127	127	126	132	134	134	135	135	-	-	-	-	-	-	-	-	-
Minority Interest	1.5%	259	256	256	248	235	229	232	229	216	218	216	205	192	180	180	166	158	151	150	123	113
Float	-	-	-	3,254	-	-	-	2,361	-	-	-	4,692	-	-	-	1,574	-	-	-	1,705	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	54.2%	179,442	116,338	234,838	51,440	12,544	94,263	171,681	6,337	-60,752	98,954	123,138	239,888	207,438	134,537	642,014	44,084	178,542	133,726	91,152	41,762	113,217
Share Based Compensation	2.9%	11,818	11,483	10,327	10,181	9,799	10,187	8,946	8,823	8,938	8,194	7,099	6,709	6,422	6,962	6,963	6,903	7,020	6,818	6,358	6,255	6,151
Cashflow From Investing	-10.4%	-69,584	-63,018	-66,813	-69,062	-57,234	-55,011	-58,763	-55,331	-99,268	-69,081	-35,660	-52,585	-53,168	18,377	-35,903	-44,659	-46,019	-43,231	-144,680	-82,799	-50,595
Cashflow From Financing	-34.1%	-103,292	-77,047	-150,561	3,419	34,373	-25,698	-149,130	105,565	-513,653	-85,383	-34,259	-14,090	-217,009	-22,851	-169,537	-262,144	67,396	-78,568	29,749	13,674	-47,857
Dividend Payments	0.1%	16,048	16,035	15,924	15,897	15,897	15,893	16,108	16,691	16,784	16,940	16,876	-	-	-	-	-	-	-	-	-	-
Buy Backs	-82.1%	1,709	9,544	1,506	-	1,914	14,991	126,947	51,676	13,426	64,440	1,610	-	1,792	4,827	724	8,691	1,222	23,689	13,620	-	1,197

SEM Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 6,664,058	$ 6,333,538	$ 6,204,515
Costs and expenses:
Cost of services, exclusive of depreciation and amortization	5,732,017	5,600,161	5,285,149
General and administrative	170,193	153,035	146,975
Depreciation and amortization	208,742	205,825	202,645
Total costs and expenses	6,110,952	5,959,021	5,634,769
Other operating income	1,768	28,766	144,028
Income from operations	554,874	403,283	713,774
Other income and expense:
Loss on early retirement of debt	(14,692)	0	0
Equity in earnings of unconsolidated subsidiaries	40,813	26,407	44,428
Gain on sale of businesses	0	0	2,155
Interest income	0	0	5,350
Interest expense	(198,639)	(169,111)	(135,985)
Income before income taxes	382,356	260,579	629,722
Income tax expense	82,625	62,553	129,773
Net income	299,731	198,026	499,949
Less: Net income attributable to non-controlling interests	56,240	39,032	97,724
Net income attributable to Select Medical Holdings Corporation	$ 243,491	$ 158,994	$ 402,225
Earnings per common share (Note 19):
Basic (in dollars per share)	$ 1.91	$ 1.23	$ 2.98
Diluted (in dollars per share)	$ 1.91	$ 1.23	$ 2.98

SEM Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 84,006	$ 97,906
Accounts receivable	940,335	941,312
Prepaid income taxes	22,726	31,868
Current portion of interest rate cap contract	58,962	74,857
Other current assets	151,617	125,370
Total Current Assets	1,257,646	1,271,313
Operating lease right-of-use assets	1,188,616	1,169,740
Property and equipment, net	1,023,561	1,001,440
Goodwill	3,513,170	3,484,200
Identifiable intangible assets, net	329,916	351,662
Interest rate cap contract, net of current portion	0	45,200
Other assets	376,722	341,738
Total Assets	7,689,631	7,665,293
Current Liabilities:
Overdrafts	30,274	31,961
Current operating lease liabilities	245,400	236,784
Current portion of long-term debt and notes payable	70,329	44,351
Accounts payable	174,312	186,729
Accrued payroll	238,768	209,789
Accrued vacation	157,748	150,695
Accrued interest	32,472	29,837
Accrued other	297,663	264,525
Income taxes payable	1,499	480
Total Current Liabilities	1,248,465	1,155,151
Non-current operating lease liabilities	1,025,867	1,008,394
Long-term debt, net of current portion	3,587,675	3,835,211
Non-current deferred tax liability	143,306	169,793
Other non-current liabilities	110,303	106,137
Total Liabilities	6,115,616	6,274,686
Commitments and contingencies (Note 20)
Redeemable non-controlling interests	26,297	34,043
Stockholders’ Equity:
Common stock, $0.001 par value, 700,000,000 shares authorized, 127,173,871 and 128,369,492 shares issued and outstanding at 2022 and 2023, respectively	128	127
Capital in excess of par	493,413	452,183
Retained earnings	751,856	581,010
Accumulated other comprehensive income	42,907	88,602
Total Stockholders’ Equity	1,288,304	1,121,922
Non-controlling interests	259,414	234,642
Total Equity	1,547,718	1,356,564
Total Liabilities and Equity	$ 7,689,631	$ 7,665,293

About Select Medical Holdings Corp

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: The Critical Illness Recovery Hospital, The Rehabilitation Hospital, The Outpatient Rehabilitation, and The Concentra. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

CEO	Mr. David S. Chernow
WEBSITE	selectmedical.com
INDUSTRY	Healthcare Plans
EMPLOYEES	37800

Select Medical Holdings Corp Frequently Asked Questions

What is the ticker symbol for Select Medical Holdings Corp? What does SEM stand for in stocks?

SEM is the stock ticker symbol of Select Medical Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Select Medical Holdings Corp (SEM)?

As of Tue Apr 23 2024, market cap of Select Medical Holdings Corp is 3.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SEM stock?

You can check SEM's fair value in chart for subscribers.

What is the fair value of SEM stock?

You can check SEM's fair value in chart for subscribers. The fair value of Select Medical Holdings Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Select Medical Holdings Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SEM so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Select Medical Holdings Corp a good stock to buy?

The fair value guage provides a quick view whether SEM is over valued or under valued. Whether Select Medical Holdings Corp is cheap or expensive depends on the assumptions which impact Select Medical Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SEM.

What is Select Medical Holdings Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, SEM's PE ratio (Price to Earnings) is 14.85 and Price to Sales (PS) ratio is 0.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SEM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Select Medical Holdings Corp's stock?

In the past 10 years, Select Medical Holdings Corp has provided 0.079 (multiply by 100 for percentage) rate of return.